CareDx (CDNA) Tops Q4 EPS by 28c, provides guidance

CareDx (NASDAQ: CDNA) reported Q4 EPS of ($0.17), $0.28 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $65.6 million versus the consensus estimate of $62.63 million.

GUIDANCE:

CareDx sees FY2024 revenue of $260-274 million, versus the consensus of $260.7 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight
• Hyperscale Data launches $300M at-the-market stock offering